Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2008-05-06
2008-05-06
Wehbe, Anne Marie (Department: 1633)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100
Reexamination Certificate
active
10348304
ABSTRACT:
A nucleotide sequence encoding human serum amyloid A3 (SAA3), isolated, purified and characterized from human mammary epithelial cells is disclosed. Proteins encoded thereby and methods of use for the same are also disclosed.
REFERENCES:
patent: 4377569 (1983-03-01), Plymate
patent: 4425330 (1984-01-01), Norcross et al.
patent: 4755380 (1988-07-01), Grubb
patent: 4952496 (1990-08-01), Studier
patent: 5227301 (1993-07-01), Turner et al.
patent: 5536640 (1996-07-01), Sipe et al.
patent: 5585098 (1996-12-01), Coleman
patent: 5700465 (1997-12-01), Tao et al.
patent: 5807684 (1998-09-01), Simmons et al.
patent: 5853985 (1998-12-01), Salbaum
patent: 5952313 (1999-09-01), Carlson
patent: 5958883 (1999-09-01), Snow
patent: 6004936 (1999-12-01), Kisilevsky
patent: 6013857 (2000-01-01), Deboer
patent: 0872 558 (1998-10-01), None
patent: 1 067 194 (2001-01-01), None
patent: WO/95/21625 (1995-08-01), None
patent: WO/97/04317 (1997-02-01), None
patent: WO/97/06184 (1997-02-01), None
patent: WO/98/03206 (1998-01-01), None
patent: WO/98/40506 (1998-09-01), None
patent: WO/99/18227 (1999-04-01), None
patent: WO 01 14580 (2001-03-01), None
patent: WO/01/31006 (2001-03-01), None
Bowie, et al. Science, 247: 1306-10, 1990.
Skolnick et al. TIBTECH 18:34-39, 2000.
Bauman, H., et al., “The acute phase response”, IT Review, 1994 Elsevier Science Ltd., 0167-5699/94.
Benson, M. Douglas, “A unique insertion in the primary structure of bovine amyloid AA protein” J. Lab Clin Med., vol. 113:67-72, 1989.
Hirvonen, Juhani, et al, “Acute phase response in heifers with experimentally induced mastitis” Journal of Dairy Research (1996) 63 352-360.
Hulten, C., et al., “The acute phase serum amyloid A protein (SAA) in the horse: isolation and characterization of three isoforms”, Veterinary Immmunology and Immunopathology 57(1997) 215-227.
Huszenicza, Gy., et al. “Diagnostic Value of Certain Mastitis Markers in Following up the Clinical and Bacteriological Change in Pharmacotherapeutic Studies” University of Veterinary Science, Budapest, Hungary 45(4) pp. 409-416 (1997).
Jensen, L., et al., “Regulation of serum amyloid A protein expression during the acute-phase response”, Biochem J. (1998) 334:489-503.
Kho Y.J., et al., “Cloning and characterization of involution-specific genes from the bovine mammary gland” Database EMBL accession No. AF160867 'Online! Jun. 30, 2000.
Kho, Y.J., et al., GenBank Submission AAF77630, serum amyloid A protein [Bos tauru].
Kho, Y.J., et al., Rapid Communication: Cloning of bovine serum amyloid A3cDNA1, American Society of Animal Science, May 19, 2000.
Kluve-Beckerman, Barbara et al., “Primary Structures of Dog and Cat Amyloid A Proteins: Comparison to Human AA” Comp. Biochem. Physiol. vol. 94B, No. 1, pp. 175-183, 1989.
Kluve-Beckerman, Barbara, et al. “Human Serum Amyloid A—Three Hepatic mRNAs and the Coresponding Proteins in One Person” The Journal of Clinical Investigation, Inc., vol. 82, Nov. 1988 pp. 1670-1675.
Liang, Jun-shan, et al., “Amino terminao region of acute phase, but not constitutive, serym amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells”, Journal of Lipid Research (1996) 37:2109-2116.
Liepnieks, J., et al., “The primary structure of serum amyloid A protein in the rabbit: Comparison with serum amyloid A proteins in other species”, J Lab Clin Med (1991) 118(6):570-576.
Malle, E., “Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice”, European Journal of Clinical Investigation (1996) 26::427-435.
Marhaug, Gudmund, et al. “Mink Serum Amyloid A Protein. Expression and primary structure based on cDNA”, J. Biol. Chem., vol. 265:10049-10054, 1990.
McDonald, T., et al., “A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein”, J. of Immunological Methods, 144 (1991) 149-155.
McDoanld, T., et al. “Elevated extrahepatic expression and secretion of mammary-associated serum amyloid A3 (M-SAA3) into colostrums” Veterinary Immunology and Immunopathology 6528 (2001) 1-9.
Migita, K., et al., “Serum Amyloid A Protein Induces Production of Matrix Metalloproteinases by Human Synovial Fibroblasts”, Laboratory Investigation, 78(5):535-539 (1998).
Mitchell, T., et al., “The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin”, Biochem et Biophysica Acta. 1156 (1998) 245-254.
Mitchell, T.I., et al., “Serum Amyloid A (SAA3) Produced by Rabbit Synovial Fibroblasts Treated with Phorbol Esters or Interlaukin 1 induces Synthesis of Collagenase and is Neutralized with Specific Antiserum”,J. Clinical Investigation87(4):1177-1185 (1991).
Patel, H., “Human Serium Amyloid A has Cytokine-Like Properties”, Scand. J. Immunol. 1998, 48:410-418.
Peristeris, P., “Effects of serum amyloid A protein on lymphocytes, HeLa, and MRC5 cells in culture”, Biochem. Cell Biol., (1989) 67:365-370.
Rossevatn, K., et al., “The complete amino acid sequence of bovine serum amyloid protein A (SAA) and of subspecies of the tissue-deposited amyloid fibril protein A”,Scand. J. Immunol.35(2):217-24 (1992).
Satoh, Megumi, et al, “Sandwich enzyme-linked immunosorbent assay for quantitative measurement of serum amyloid A protein in horses” Am J Vet Res., vol. 56, No. 10, Oct. 1995.
Sletten, K., “The Primary Structure of Equine Serum Amyloid A (SAA) Protein”,Scand. J. Immunol.30(1):117-122 (1989).
Sletten, K., et al., “The Amino Acid Sequence of an Amyloid Fibril Protein AA Isolated from the Horse”, Scand. J. Immunol. 26, 79-84, 1987.
Smith, J., et al., “Comparison of Serum Amyloid A and C-Reactive Protein as Indicators of Lung Inflammation in Corticosteroid Treated and Non-Corticosteroid Treated Cystic Fibrosis Patients”, Journal of Clinical Laboratory Analysis 6:219-224 (1992).
Smith, J., et al., “Production of serum amyloid A and C-reactive Protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone”, Clin. exp. Immunol. (1992) 783.
Smith, J., et al., “Use of Ethanol-Eluted Hydrophobic Interaction Chromatography in the Purification of Serum Amyloid A”, Protein Expression and Purification 2:158-161 (1991).
Steel, D., et al., “Expression and regulation of Constitutive and Acute Phase Serum Amyloid A mRNAs in Hepatic and Non-Hepatic Cell Lines”, 1996, Blackwell Science Ltd., Scandinavian Journal of Immunology, 44:493-500.
Steel, D., et al., “The major acute phase reactants: C-reactive protein, serum amyloid P component and serum and amyloid A protein”, Review, 1994 Elsevier Science Ltd, 0167-5699/94.
Syversen, P.V., et al., “The Primary Structure of Serum Amyloid A Protein in the Sheep; Comparison with Serum Amyloid A in Other Species” Scand. J. Immuno., vol. 39:88-94, 1994.
Taktak, Y.S., et al., “A solid phase enzyme immunoassay for serum amyloid A (SAA) protein”, Journal of Immunological Methods, 136 (1991) 11-16.
Thompson, D., et al., “The value of acute phase protein measurements in clinical practice”, Ann Clin Biochem 1992, 29:123-131.
Uhlar, C., “Evolution of the Serum Amyloid A (SAA) Protein Superfamily”, Genomics 19:228-235 (1994).
Urieli-Shoval, S., et al., “Widespread Expression of Serum Amyloid A in Histologically Normal Human Tissues: Predominant Localization of the Epithelium”, The Journal of Histochemistry & Cytochemistry 46(12):1377-1384 (1998).
Waalen, Kristian, et al., “The Primary Structure of Amyloid Fibril Protein AA in Endotoxin-Induced Amyloidosis of the Mink”, European Journal of Biochem, vol. 104:407-412 (1980).
Wilkins, Julie, et al., “Rapid Aut
Larson Marilynn A.
McDonald Thomas L.
Weber Annika
McKee Voorhees & Sease, P.L.C.
Sajjadi Fereydoun G.
The Board of Regents of the University of Nebraska
Wehbe Anne Marie
LandOfFree
Human SAA3 nucleic acid molecule, protein, and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human SAA3 nucleic acid molecule, protein, and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human SAA3 nucleic acid molecule, protein, and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3911747